The Ephrin receptor A2 and Roundabout Guidance Receptor 1 heterodimer: A potential theranostic for squamous cell carcinomas
K. M. Pang, S. Srivastava, M. Iida, M. Nelson, J. Liu, A. Nam, J. Wang, I. Mambetsariev, A. Mohanty, N. McDaniel, A. Behal, P. Kulkarni, D. L. Wheeler, R. Salgia
The paper shows that the EPHA2-ROBO1 heterodimer reduces growth of lung and head and neck squamous cell carcinomas and suggests SLIT2 and Ensartinib as potential therapies.
bioRxiv · Apr 9, 2020 · PreprintCancer Biology